EMA Gilead Sciences announced that the company’s Marketing Authorization Application (MAA) for lenacapavir, an investigational, long─acting HIV─1 capsid inhibitor, has been fully validated and is now under...

FDA Approves Linzess to Treat Constipation in Children The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with...

What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow...

(Reuters) – Johnson & Johnson’s drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.